Los Angeles, California
Sleep disorder clinical trials in Los Angeles, CA
12 sleep disorder studies are recruiting participants at sites in Los Angeles as of November 16, 2026, according to ClinicalTrials.gov. Sleep Study Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Los Angeles at a glance
- 12 studies are recruiting at a site in Los Angeles.
- By phase: Phase 2 (1), Phase 2/3 (1), Phase 3 (4), No phase (5), Observational (1). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (6), industry (5), government (1).
- By research area: Insomnia (5), Narcolepsy (5), Sleep Apnea (2).
- Most recent update to one of these records: November 13, 2026.
Insomnia studies recruiting in Los Angeles
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
UCLA REST Study (REsearch on Sleep Techniques)
- No phase
- Ages 18 to 22
- All sexes
- Sponsor
- University of California, Los Angeles
- Study site
- University of California, Los Angeles
- Registry record
- NCT05576090 · updated
Multi-center Trial to Improve Nocturia and Sleep in Older Adults
- No phase
- Ages 60 and older
- All sexes
- Sponsor
- Atlanta VA Medical Center
- Study site
- VA Greater Los Angeles Healthcare System
- Registry record
- NCT06110091 · updated
Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth
- No phase
- Ages 12 to 18
- All sexes
- Sponsor
- Children's Hospital Los Angeles
- Study site
- Children's Hospital Los Angeles
- Registry record
- NCT07213908 · updated
Sleep Learning Education and Empowerment for Older Korean Immigrants
- No phase
- Ages 60 and older
- All sexes
- Sponsor
- University of California, Los Angeles
- Study site
- University of California Los Angeles
- Registry record
- NCT07387406 · updated
Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder
- No phase
- Ages 18 to 50
- All sexes
- Sponsor
- University of California, Los Angeles
- Study site
- Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles
- Registry record
- NCT05499741 · updated
Source: ClinicalTrials.gov. Data processed . See every insomnia study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Sleep apnea studies recruiting in Los Angeles
Down Syndrome Obstructive Sleep Apnea
- Phase 2
- Ages 5 to 18
- All sexes
- Sponsor
- Brigham and Women's Hospital
- Study site
- Children's Hospital of Los Angeles
- Registry record
- NCT06043440 · updated
Neurocognition in Congenital Central Hypoventilation Syndrome (CCHS)
- Observational
- Ages 3 to 85
- All sexes
- Sponsor
- Ilya Khaytin
- Study site
- Children's Hospital Los Angeles
- Registry record
- NCT03568669 · updated
Source: ClinicalTrials.gov. Data processed . See every sleep apnea study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Narcolepsy studies recruiting in Los Angeles
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Harmony Biosciences Management, Inc.
- Study site
- Santa Monica Clinical Trials
- Registry record
- NCT07675135 · updated
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Phase 2/3
- Ages 18 to 70
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigational Site
- Registry record
- NCT06767683 · updated
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Jazz Pharmaceuticals
- Study site
- Santa Monica Clinical Trials
- Registry record
- NCT07625280 · updated
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Phase 3
- Ages 18 to 70
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigational Site
- Registry record
- NCT07455383 · updated
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Phase 3
- Ages 18 to 70
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigational Site
- Registry record
- NCT07502443 · updated
Source: ClinicalTrials.gov. Data processed . See every narcolepsy study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Ask about studies near Los Angeles
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
58 studies recruiting across 31 cities.
San Francisco
9 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Sleep Study Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections